Form 4: Doximity Director Kira Scherer Wampler Executes Stock Option and Sells Shares Under 10b5-1 Plan

Director Kira Scherer Wampler exercised stock options and sold shares of Doximity, Inc. Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On April 1, 2025, Kira Scherer Wampler, a director of Doximity, Inc., executed a stock option to acquire 7,000 shares of Class A Common Stock at a price of $1.54.
• Simultaneously, Wampler converted 7,000 shares of Class B Common Stock into Class A Common Stock.
• Wampler also sold 6,186 shares of Class A Common Stock at a weighted-average price of $57.6267 and 814 shares at a weighted-average price of $58.3146.
• These sales were executed automatically under a Rule 10b5-1 trading plan adopted on November 12, 2024.
• Following these transactions, Wampler directly owns 16,618 shares of Class A Common Stock and 478,700 stock options exercisable for Class B Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transactions are part of a pre-planned trading strategy. There's no indication of positive or negative sentiment towards the company's prospects.

Positives

• The director's transactions are being conducted under a pre-arranged 10b5-1 trading plan, which is generally viewed as a transparent and orderly way to manage stock sales.

Risks

• While the 10b5-1 plan provides some insulation, large sales by insiders could still be perceived negatively by the market.

Industry Context

Insider transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. However, transactions under 10b5-1 plans are less informative as they are pre-arranged.

Comparison to Industry Standards

• Monitoring insider trading activity is a common practice in the financial industry.
• Comparing Wampler's transactions to those of other directors in similar healthcare technology companies could provide a benchmark, but the 10b5-1 plan makes direct comparisons less meaningful.
• Companies like Teladoc Health (TDOC) and Veeva Systems (VEEV) also have directors who utilize 10b5-1 plans, so this activity is not unusual.

Stakeholder Impact

• The transactions could have a minor impact on shareholders due to the potential for slight price fluctuations, but the 10b5-1 plan mitigates concerns about insider information.

Key Dates

Keywords

Form 4, insider trading, stock option, Rule 10b5-1, Doximity, DOCS, Wampler, director, Class A Common Stock, Class B Common Stock